Frédéric Porte
Fondateur chez Medipress Management, Inc.
Profil
Mr. Porte joined Genesys in 2008.
He is a seasoned entrepreneur and businessman with several years of experience in the life sciences industry.
During his career, he has founded 3 successful companies.
Mr. Porte is currently the President and Founder of Medipress Management Inc., a firm offering financial and strategic services to healthcare and venture capital organizations for the evaluation of M&A and strategic alliances.
Prior to that, he founded in 1987 Clinidata, a software and communication company developed in association with Royal Bank Capital Corporation and specialized in healthcare applications.
Clinidata developed effective and sophisticated technologies supported by multinational corporations such as Merck, Pfizer, J&J, Schering Plough and Smith Kline Beecham, combined with strategic alliances with managed care organizations and professional associations.
The company was acquired in 1994 by the pharmaceutical company Hoechst Marion Roussel.
In 1980, he created and managed L'Actualité Médicale, a leading Canadian medical publishing company which was later acquired by MacLean Hunter.
Mr. Porte has a degree in Business Administration and Finance from l'école Supérieure de Commerce de Lyon (France) and a D.E.A.
in Information Sciences from the University of Sorbonne (France).
He is a member of the Board of Directors of Labopharm Inc. He is also a director of Angelus Investment Corporation.
Postes actifs de Frédéric Porte
| Sociétés | Poste | Début |
|---|---|---|
| Medipress Management, Inc. | Fondateur | 20/08/2009 |
Anciens postes connus de Frédéric Porte
| Sociétés | Poste | Fin |
|---|---|---|
Avance Pharma, Inc.
 Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | 01/01/2005 |
| Clinidata, Inc. | Fondateur | 01/01/1994 |
| L’Actualité Médicale, Inc. | Fondateur | - |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Private Equity Investor | - |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Président | - |
Formation de Frédéric Porte
| EM Lyon Business School | Undergraduate Degree |
| Ecole de Commerce Européenne Bordeaux et Lyon | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
| Medipress Management, Inc. | |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Finance |
Avance Pharma, Inc.
Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Health Technology |
| Clinidata, Inc. | |
| L’Actualité Médicale, Inc. |
